Thursday, July 30, 2020
Biocon Biologics valued at $3.5 billion after Tata Capital's $30 million financing
Through investments in R&D and high-quality manufacturing infrastructure, we are confident of achieving our aspiration of serving 5 million patients through our biosimilars portfolio, CEO Hamachar said https://ift.tt/33dByn4 https://ift.tt/eA8V8J
Subscribe to:
Post Comments (Atom)
Sources: after five Thinking Machines staff left, investors are rattled, potentially impacting fundraising; two researchers quit via Slack during an all-hands (The Information)
The Information : Sources: after five Thinking Machines staff left, investors are rattled, potentially impacting fundraising; two researc...
-
http://bit.ly/2XqNIDz
-
Amrith Ramkumar / Wall Street Journal : An interview with White House OSTP Director Michael Kratsios, a Peter Thiel protégé confirmed by ...
No comments:
Post a Comment